comparemela.com

Page 6 - Life Edit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novo Nordisk strikes gene editing deal with Durham-based Life Edit

Gene editing from a Durham-based firm that will target possible new therapeutics has led to a deal with international drug firm Novo Nordisk worth a potential $2 billion if not more. Here are the details.

Moderna, Inc (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript

Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates

Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.